Press Releases

18 have been found

Advanced search
Categories
Years
Number of results per page
1 2 | »

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Corporate

DBV Technologies CEO, Chairman, and Co-Founder, Dr. Pierre-Henri Benhamou Recognized for His Lasting Impact on the Food Allergy Community and Research Advancement by FARE (Food Allergy Research & Education)

Conferences

DBV Technologies to Attend Citi’s 2017 Global Healthcare Conference

Clinical

DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients

Science

DBV Technologies Announces Publication of Positive Data from Phase IIb Trial and Long-Term Study of Viaskin Peanut inthe Journal of the American Medical Association

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Finance

DBV Technologies Reports September 30, 2017 Cash Position

Clinical

DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age

Monthly information regarding the total number of voting rights and total number of shares of the Company 

Clinical

DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut

1 2 | »